VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
NCT ID: NCT06560034
Last Updated: 2024-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2024-08-15
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor
NCT06980766
Non-invasive and Continuous Blood Pressure Monitoring
NCT06887465
NIBP Validation Study
NCT05673408
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
NCT06147336
Clinical Evaluation of the Vital Signs Monitoring System (VSMS)
NCT03206528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical Rationale This study will compare the accuracy of the 80 Beats Medical noninvasive blood pressure measurement using the VicorderCS device with that of human observers' readings using the auscultatory method, as required by the applicable ISO standard: Non-invasive sphygmomanometers part 2 - clinical investigation of intermittent automated measurement type1. The study will aim to enroll 120 participants for blood pressure readings using both the VicorderCS and auscultatory method using a calibrated aneroid sphygmomanometer.
Design Rationale The VicorderCS blood pressure study will be conducted using consenting participants in Summit County Colorado and designed to be compliant with the requirements within the applicable ISO standard1. Study data, including systolic and diastolic blood pressure readings, will be collected using both the VicorderCS and auscultatory method using a sphygmo-manometer.
Proposed Solution 80 Beats Medical has developed the VicorderCS, which is indicated for the non-invasive measurement of blood pressure to detect cardiovascular health risks.
Device Description
VicorderCS consists of the following components:
1. Vascular Sensor (VCS-VAS-1000) measurement device used with accessories (cuffs and tubes) connected to the device;
2. Data Station (VCS-DAT-1000) for data collection and analysis
Platform Data Privacy and Security The VicorderCS application follows industry best practices for data privacy and security, including compliance with applicable laws and regulations such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA). 80 Beats Medical has implemented technical and organizational measures to safeguard user data against unauthorized access, disclosure, alteration, or destruction, and regularly conducts security audits and risk assessments to identify and mitigate potential threats.
80 Beats Medical has established policies and procedures to ensure that user data is used only for its intended purpose and is not shared with unauthorized parties.
There are two data sets that will be recorded during this study. One is the pressure waveforms on all four limbs and the other is the Systolic and Diastolic blood pressure measurement on the left arm. All data on the vascular sensor will be deleted after the test is complete. However, the pressure waveforms will be uploaded to the data station before being deleted. This will be part of an internal data pool for use in perpetuity.
Users are provided with transparency and control over their data, including the ability to access, correct, and delete their information. Users can opt out of data collection and sharing, where applicable. Security and privacy of user data are critical to maintaining user trust, and 80 Beats Medical is committed to ensuring the application meets the highest standards for data privacy and security.
STUDY OBJECTIVES Primary Objective The objective of this study is to collect blood pressure readings using the VicorderCS device. We will subsequently conduct statistical analysis by comparing to the traditional sphygmomanometer method according to the ISO standard.
Secondary Objectives A secondary objective of this study is to collect raw waveform data on the opposite arm, and both ankles in order to optimize analysis capabilities in the future.
INVESTIGATIONAL PLAN General Schema of Study Design In this cross-sectional study, we will look at the systolic (Sys) and diastolic (Dia) blood pressure of 120 subjects (ages 18 years or older).
The primary hypothesis of this study is that the VicorderCS can detect and analyze blood pressure in an easy-to-use and portable device providing more complete diagnostics at the point of care.
Study Device 80 Beats Medical has developed the VicorderCSCS, which is indicated for the non-invasive measurement of blood pressure.
Indications for use The VicorderCS Device is indicated for adult patients needing a blood pressure reading.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cross-Sectional Group
Blood pressure reading of one group of participants
VicorderCS
1. Vascular Sensor (VCS-VAS-1000) measurement device used with accessories (cuffs and tubes) connected to the device;
2. Data Station (VCS-DAT-1000) for data collection and analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VicorderCS
1. Vascular Sensor (VCS-VAS-1000) measurement device used with accessories (cuffs and tubes) connected to the device;
2. Data Station (VCS-DAT-1000) for data collection and analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be 18 years old or older, inclusive at enrollment
* Must be willing to provide blood pressure measurement
* Must be able to read, understand, and willingly sign an Informed Consent Form
* Must be able to read, speak and understand English
* Must be available to attend one study visit at: please specify exact location.
Exclusion Criteria
* No active email address
* Non-English or Spanish- speaking
* Unable to read in English.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
80 Beats Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nitin Vaswani, MD
Role: PRINCIPAL_INVESTIGATOR
PI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manos Health Study Site
Breckenridge, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00080976
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.